Financial Times amends article omitting terror conviction of “human rights defender”

A Financial Times article (“EU-funded West Bank activists hacked by Pegasus spyware, says rights group”, Nov. 9th) by Mehul Srivastava included the following about Ubai al-Aboudi, director of Bisan Center for Research and Development, one of the six NGOs recently declared a PFLP terrorist front:

Ubai al-Aboudi, director of the Ramallah-based Bisan Center for Research and Development, whose phone was among those hacked, said the timing of the designation raised serious concerns. “I think that it’s very suspicious that just days after [a small group of people] found out that Pegasus was being used against Palestinian human rights defenders, we were suddenly declared to be terrorists,” he said. “This [spyware] is supposed to be only used against terrorists, and suddenly the Israeli government declares us to be terrorists. This is putting the wagon in front of the horse.”

Al-Aboudi voiced concern that his phone had been tampered with to make him appear guilty. “A program that is so intrusive, it can also be used to create false evidence,” said al-Aboudi. Aboudi is a US citizen, and said his conversations with US diplomats, could have been compromised.

However, as we noted to editors in an email yesterday, the article omits that, prior to being a “human rights defender”, Al-Aboudi was convicted and sentenced to a year in prison due to his membership in the PFLP – extremely relevant information given the context of the article.
This morning, we learned that our complaint was upheld, and the article was amended to note al-Aboudi’s previous conviction. The following editor’s note appears at the bottom of the piece.
h/t Tomer Ilan
Related Post

‘Contrarian’ British magazine takes the anti-Israel road most traveled

Written By
More from Adam Levick
Channel 4 drama about UKIP illustrates far-right protest by showing Israeli flag
A Channel 4 drama about the UK Independence Party (UKIP, the first...
Read More
Join the Conversation

1 Comment

Leave a comment
Leave a comment

Your email address will not be published. Required fields are marked *